Legal Representation
Attorney
Adam K Sacharoff
USPTO Deadlines
Application History
10 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Apr 22, 2024 | MAB2 | E | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | Loading... |
| Apr 22, 2024 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... |
| Jan 4, 2024 | XELG | O | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | Loading... |
| Jan 4, 2024 | XELR | I | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | Loading... |
| Oct 6, 2023 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Oct 6, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Oct 6, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Sep 7, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Dec 20, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Dec 1, 2022 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 042
Research and development of pharmaceuticals; Scientific research and development of therapies in the fields of biotechnology, genetic medicine, gene therapy, biologics, small molecules, DNA, RNA, proteins, vectors and payloads; Pharmaceutical products design and development for medical and scientific use, and medical treatment; Pharmaceutical drug design and development featuring biomolecules
First Use Anywhere:
20131200
First Use in Commerce:
20131200
Additional Information
Pseudo Mark
FOUR D MOLECULAR THERAPEUTICS
Classification
International Classes
042